← FDA Drug Approvals (Drugs@FDA)
ABANTA
NDA · New Drug Application · Sponsor: AZURITY · Approved 2026-06-29
Drug application
- FDA Application #
NDA221024- Application type
- New Drug Application
- Brand name
- ABANTA
- Generic name
- Apixaban
- Active ingredients
- APIXABAN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- AZURITY
- First approval
- 2026-06-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown